Markets:

Overview

News

Currencies

International

Treasuries

Boston Scientific (NY:BSX)

88.07 UNCHANGED

Streaming Delayed Price Updated: 7:00 PM EST, Jan 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Boston Scientific

< Previous 1 2

...

16 17 18 19 20 21 22 23 Next >

10 Health Care Stocks With Whale Alerts In Today's Session ↗

February 23, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Executives Sell More Than $210M Of 5 Stocks ↗

February 09, 2022

Spanish stocks traded higher this morning, with the IBEX 35 Index surging to the strongest level in over two weeks. Investors, meanwhile, focused on some notable insider trades....

Via Benzinga

What 5 Analyst Ratings Have To Say About Boston Scientific ↗

February 03, 2022

Over the past 3 months, 5 analysts have published their opinion on Boston Scientific (NYSE:BSX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...

Via Benzinga

Boston Scientific Tumbles On Lackluster Guidance Despite Fourth-Quarter Beat ↗

February 02, 2022

The company topped expectations in the fourth quarter, but guidance disappointed.

Via Investor's Business Daily

The Daily Biotech Pulse: LogicBio Genome Editing Therapy Study Placed On Clinical Hold, Gilead Q4 Disappoints On Slowing Veklury Sales ↗

February 02, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

Why Is Boston Scientific Stock Trading Lower Premarket Today? ↗

February 02, 2022

Boston Scientific Corp (NYSE: BSX) generated

Via Benzinga

Where Boston Scientific Stands With Analysts ↗

August 21, 2021

Within the last quarter, Boston Scientific (NYSE:BSX) has ob...

Via Benzinga

Boston Scientific: Q4 Earnings Insights ↗

February 02, 2022

Boston Scientific (NYSE:BSX) reported its Q4 earnings results on Wednesday, February 2, 2022 at 06:30 AM. Here's what investors need to know about the announcement.

Via Benzinga

What Does Boston Scientific's Debt Look Like? ↗

January 28, 2022

Over the past three months, shares of Boston Scientific (NYSE:BSX) increased by 0.05%. Before we understand the importance of debt, let us look at how much debt Boston...

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

January 27, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

What Does Boston Scientific's Debt Look Like? ↗

December 15, 2021

Shares of Boston Scientific (NYSE:BSX) decreased by 6.16% in the past three months. Before having a look at the importance of debt, let us look at how much debt Boston...

Via Benzinga

2 Medical Device Stocks Wall Street Predicts Will Rally 35% Or More ↗

December 09, 2021

Boston Scientific Corporation is a developer, manufacturer, and marketer of medical devices used in a range of interventional medical specialties.

Via Talk Markets

Ominous Death Cross Forms On Boston Scientific's Chart ↗

December 06, 2021

If history is any guide, there may be trouble ahead for shares of Boston Scientific (NYSE:BSX). A so-called "death cross" has formed on its chart and, not surprisingly, this...

Via Benzinga

Earnings Scheduled For February 2, 2022 ↗

February 02, 2022

Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is likely to report quarterly earnings at $1.57 per share on revenue of $24.59 billion.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 10, 2021 ↗

December 10, 2021

Upgrades According to JP Morgan, the prior rating for Arconic Corp (NYSE:

Via Benzinga

Boston Scientific Corp (BSX) Q3 2021 Earnings Call Transcript ↗

October 27, 2021

BSX earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

Boston Scientific Q3 Earnings Comes Inline With Wall Street Expectations ↗

October 27, 2021

Boston Scientific Corporation (NYSE: BSX) generated net sales of $2.93 billion in Q3 of 2021, almost in line with the Wall Street estimate of $2.97 billion. Sales...

Via Benzinga

Recap: Boston Scientific Q3 Earnings ↗

October 27, 2021

Boston Scientific (NYSE:BSX) reported its Q3 earnings results on Wednesday, October 27, 2021 at 06:30 AM. Here's what investors need to know about the announcement....

Via Benzinga

The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More ↗

October 24, 2021

Biotech stocks posted gains for the second week running, supported by multiple catalysts that included a good start to the big pharma reporting season and broader market strength...

Via Benzinga

Boston Scientific's Eluvia Drug-Eluting Vascular Stent Tops Bare Metal Stents ↗

October 06, 2021

Boston Scientific Corporation (NYSE: BSX) has announced data for the Eluvia Drug-Eluting Vascular Stent System (Eluvia stent) at the Vascular InterVentional...

Via Benzinga

Boston Scientific Beefs Up Electrophysiology, Structural Heart Portfolio With $1.75B Baylis Deal ↗

October 06, 2021

Boston Scientific Corporation (NYSE: BSX) has agreed to acquire Baylis Medical Company Inc for an upfront payment of $1.75 billion. The acquisition will...

Via Benzinga

Boston Scientific Highlights Trial Data For EkoSonic System For Pulmonary Embolism ↗

October 06, 2021

Boston Scientific Corporation (NYSE: BSX) announced results for the EkoSonic Endovascular System at the Vascular InterVentional Advances (VIVA) meeting. ...

Via Benzinga

FDA Takes Note Of Higher Risk For Women With Stroke-Preventing Implants ↗

September 29, 2021

The FDA informed health care providers of the potential for differences in procedural outcomes between women and men undergoing implant of a left atrial appendage...

Via Benzinga

Increasing Incidences of Cardiac Arrhythmias Raising Demand for Electrophysiology Medical Devices

September 21, 2021

Via FinancialNewsMedia

Boston Scientific Acquires Provider Of Thrombectomy Platform In Over $300M Deal ↗

September 21, 2021

Boston Scientific Corporation (NYSE: BSX) has agreed to acquire Devoro Medical Inc for over 300 million. Boston Scientific has been a strategic investor in...

Via Benzinga

The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data ↗

September 21, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20) Cerevel Therapeutics...

Via Benzinga

Boston Scientific Posts Colorectal Cancer Survival Data For Tumor-Targeting Microbeads ↗

September 20, 2021

Boston Scientific Corporation (NYSE: BSX) announced that the EPOCH clinical trial of the TheraSphere Y-90 Glass Microspheres (TheraSphere treatment) met both primary...

Via Benzinga

'Fast Money Halftime Report' Picks For September 15 ↗

September 15, 2021

On CNBC's "Fast Money Halftime Report," Karen Firestone said Charles Schwab (NYSE: SCHW) has a lot of new young traders who have larger accounts than Robinhood...

Via Benzinga

Abbott Says Amulet Superior To Boston Scientific's Watchman In Stroke Study ↗

August 30, 2021

Abbott Laboratories (NYSE: ABT) has announced late-breaking data from the Amulet LAA Occluder IDE trial. The head-to-head study compared Abbott's Amplatzer...

Via Benzinga

Post Market Studies Reinforce Unfavorable Risk-Benefit Profile For Boston Scientific's Vaginal Mesh ↗

August 17, 2021

Final results from postmarket surveillance studies of Boston Scientific Corporation's (NYSE: BSX) transvaginal mesh for pelvic organ prolapse (POP) have reinforced...

Via Benzinga

< Previous 1 2

...

16 17 18 19 20 21 22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Boston Scientific (NY:BSX)

All News about Boston Scientific

Starting at $3.75/week.

Subscribe Today